1-3 of 3
Patrick T. Griffin, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is There a Preferred Infusional Regimen for Patients with Relapsed/Refractory Multiple Myeloma?

Patrick T. Griffin, MD, Viet Q. Ho, PharmD, BCOP, William Fulp, Taiga Nishihori, MD, Kenneth H. Shain, MD PhD, Melissa Alsina, MD, Rachid Baz, MD
Journal: Blood
Blood (2014) 124 (21): 4757.
https://doi.org/10.1182/blood.V124.21.4757.4757
Published: 2014
Journal Articles

Multivariate Survival Analysis of Transformed Lymphoma in the Chemoimmunotherapy Era: Impact of the NCCN International Prognostic Index

Patrick T. Griffin, MD, Samir Dalia, MD, Bijal D. Shah, MD, Lubomir Sokol, MD PhD, Celeste M. Bello, MD, Paul A. Chervenick, MD, Eduardo M. Sotomayor, MD, Julio C Chavez, MD
Journal: Blood
Blood (2014) 124 (21): 2981.
https://doi.org/10.1182/blood.V124.21.2981.2981
Published: 2014
Journal Articles

Increased Treatment Intensity Is Not Associated with a Survival Benefit in Patients with Low and Intermediate Risk Mantle Cell Lymphoma, a Retrospective Analysis

Patrick T. Griffin, MD, Julio C Chavez, MD, Celeste M. Bello, MD, Lubomir Sokol, MD PhD, Paul A. Chervenick, MD, Ernesto Ayala, MD, Jianguo Tao, MD PhD, Eduardo M. Sotomayor, MD, Bijal D. Shah, MD
Journal: Blood
Blood (2014) 124 (21): 4424.
https://doi.org/10.1182/blood.V124.21.4424.4424
Published: 2014